2. Signaling Pathways
  3. Anti-infection
  4. Bacterial

Bacterial

Bacterial

Related Products

PDF 14.26 MB

Anything that destroys bacteria or suppresses their growth or their ability to reproduce. Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. Many antibacterial products for cleaning and handwashing are sold today. Such products do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy persons. This does not preclude the potential contribution of antibacterial products to reducing symptoms of bacterial diseases in the home.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-124508
    Lambertellin
    		Inhibitor
    Lambertellin is an effective antibiotic that can be used as a bactericide and as a fungicide. Lambertellin exerts its anti-inflammatory effect in LPS (HY-D1056)-stimulated RAW 264.7 macrophage cells by modulating the activation of the MAPK and NF-κB signaling pathways.
    Lambertellin
  • HY-169635
    Mycobacterium Tuberculosis-IN-6
    		Inhibitor
    Mycobacterium Tuberculosis-IN-6 (compound b1) is an inhibitor of Mycobacterium tuberculosis enoyl reductase InhA, with IC50 of 7.74 μM. Mycobacterium Tuberculosis-IN-6 can be used for antibacterial research.
    Mycobacterium Tuberculosis-IN-6
  • HY-N14881
    Monorden E
    		Inhibitor
    Monorden E has the effect of arresting the cell cycle of Jurket cells in G1 and G2/M phases. Monorden E has anti-Aspergillus niger activity.
    Monorden E
  • HY-183711
    Antibacterial agent 344
    		Inhibitor
    Antibacterial agent 344 is an antibacterial agent with potent biofilm inhibition (IC50 = 0.27 μM). Antibacterial agent 344 inhibits heme oxygenase (HemO), impairs iron homeostasis, virulence factor production, and motility. Antibacterial agent 344 synergizes with Ciprofloxacin (HY-B0356) and Tobramycin (HY-B0441), enhancing their efficacy and delaying the development of resistance. Antibacterial agent 344 improves bacterial-infected Galleria mellonella survival, and reduces bacterial load in mice wounds. Antibacterial agent 344 can be used for the research of Pseudomonas aeruginosa infections.
    Antibacterial agent 344
  • HY-107053
    BC-1175
    		Inhibitor
    BC-1175 (CB-181963) is a novel cephalosporin and antibacterial agent. CB-181963 displays strong binding to altered PBP 2a. CB-181963 demonstrates marked efficacy against MRSA, Klebsiella pneumoniae, Streptococcus pneumoniae, and Escherichia coli.
    BC-1175
  • HY-178105
    LQFM326
    		Inhibitor
    LQFM326 is an antimycobacterial agent. LQFM326 shows MIC of 15.6 μg/mL against Mycobacterium tuberculosis H37Ra and 12.5 μg/mL against clinical strains. LQFM326 can cause depressions and pores to appear on the surface of the mycobacterium causing abscesses, shortening the bacterial length, increasing its thickness, and damaging the integrity of the cell wall. LQFM326 can be used for the research of tuberculosis.
    LQFM326
  • HY-N6043R
    Hydroxytyrosol acetate (Standard)
    		Inhibitor
    Hydroxytyrosol acetate (Standard) is the analytical standard of Hydroxytyrosol (HY-N0570). This product is intended for research and analytical applications. Hydroxytyrosol acetate is an orally active, blood-brain barrier-permeable multi-active compound with multiple effects including antibacterial, antioxidant, anti-platelet aggregation, and neuroprotective activities. Hydroxytyrosol acetate not only inhibits the growth of Vibrio by increasing bacterial membrane permeability, but also interacts with DNA and mediates supercoiled DNA relaxation. Meanwhile, Hydroxytyrosol acetate effectively reduces thrombosis and inhibits lipid oxidation by inhibiting COX activity and promoting vascular nitric oxide production. In terms of neuroprotection, Hydroxytyrosol acetate significantly alleviates neuronal apoptosis and inflammatory responses by up-regulating the expression level of ERβ, thereby improving cognitive function in Alzheimer's disease models. Hydroxytyrosol acetate has been widely used in scientific research related to Vibrio infection, arterial thrombosis, Alzheimer's disease and other related fields.
    Hydroxytyrosol acetate (Standard)
  • HY-15781R
    Morinidazole (Standard)
    		Inhibitor
    Morinidazole (Standard) is the analytical standard of Morinidazole. This product is intended for research and analytical applications. Morinidazole is an orally active and 5-nitroimidazole antimicrobial agent that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation. Morinidazole can be used for bacterial infections research including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria.
    Morinidazole (Standard)
  • HY-161065
    HKI12134085
    		Inhibitor
    HKI12134085 (compound 3) is an orally available antibacterial nitrobenzothiazinone (BTZ) derivative with activity against Mycobacterium tuberculosis. HKI12134085 has in vivo inhibitory potency in a BALB/c mouse model of Mycobacterium tuberculosis infection.
    HKI12134085
  • HY-B0465R
    Oxacillin sodium monohydrate (Standard)
    		Inhibitor
    Oxacillin (sodium monohydrate) (Standard) is the analytical standard of Oxacillin (sodium monohydrate). This product is intended for research and analytical applications. Oxacillin sodium monohydrate is an antibiotic similar to Flucloxacillin used in resistant staphylococci infections study.
    Oxacillin sodium monohydrate (Standard)
  • HY-N14674
    Permetin A
    		Inhibitor
    Permetin A is a peptide antibiotic. Permetin A has anti-Gram-negative bacteria, Gram-positive bacteria and anaerobic bacteria activity.
    Permetin A
  • HY-N14750
    Emimycin
    		Inhibitor
    Emimycin has anti-Gram-positive bacteria, negative bacteria and brewer's yeast and other fungal activities.
    Emimycin
  • HY-175723
    MAO-A/B-IN-4
    		Inhibitor
    MAO-A/B-IN-4 is an orally active MAO-A/B inhibitor, with IC50 values of 51.3 μM and 47.0 μM, respectively. MAO-A/B-IN-4 exhibits potent activity against S. aureus, MSSA, MRSA, LRSA, and LREFa. MAO-A/B-IN-4 demonstrates potent antibacterial efficacy in a mouse model of LRSA peritonitis infection. MAO-A/B-IN-4 can be used for the study of bacterial infections.
    MAO-A/B-IN-4
  • HY-B1374S
    ent-Florfenicol-d3
    		Inhibitor
    ent-Florfenicol-d3 is the deuterium labeled Florfenicol. Florfenicol, a commonly used veterinary antibiotic, is currently indicated for the treatment of bovine respiratory disease, and also used in aquaculture for the control of enteric septicemia in catfish. Florfenicol can induce early embryonic death in eggs, with an LC50 of 1.07 μg/g.
    ent-Florfenicol-d<sub>3</sub>
  • HY-182535
    Tuberactinomycin-O
    		Inhibitor
    Tuberactinomycin-O is a peptide antibiotic belonging to the tuberactinomycin family. Tuberactinomycin-O inhibits the growth of various bacteria, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Mycobacterium ATCC 607. Tuberactinomycin-O exhibits acute toxicity in male mice when administered intravenously. Tuberactinomycin-O can be used in the research of tuberculosis.
    Tuberactinomycin-O
  • HY-113698
    L 652813
    		Inhibitor
    L 652813 is a quaternary ammonium heterocyclic amino β-lactam compound. L 652813 exhibits inhibitory activity against a broad spectrum of aerobic and anaerobic bacteria in vitro. L 652813 also exhibits good antibacterial activity in a mouse experimental bacteremia model.
    L 652813
  • HY-B0024R
    Prulifloxacin (Standard)
    		Inhibitor
    Prulifloxacin (Standard) is the analytical standard of Prulifloxacin. This product is intended for research and analytical applications. Prulifloxacin (NM441) is an orally active fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and -negative bacteria. Prulifloxacin is a proagent of a thiazeto-quinoline carboxylic acid derivative Ulifloxacin (NM394). Prulifloxacin has the potential for lower urinary tract infections and exacerbations of chronic bronchitis.
    Prulifloxacin (Standard)
  • HY-N10050
    Coreoside B
    		Inhibitor
    Coreoside B (14-Hydroxycoreoside A) can be isolated from Coreopsis tinctoria Nutt. and has weak antibacterial activity.
    Coreoside B
  • HY-129280
    Janthinocin A
    		Inhibitor
    Janthinocin A has strong activity of anti-Gram-positive bacteria and moderate anti-Gram-negative bacteria.
    Janthinocin A
  • HY-N14541
    Saframycin B
    		Inhibitor
    Saframycin B has the effect of anti-Gram-positive bacteria. Saframycin B also has weak activity against mycobacteria.
    Saframycin B
Cat. No. Product Name / Synonyms Application Reactivity